MUMBAI, Sept 1 India's Cipla Ltd has
launched an anti-asthma inhaler in Germany and Sweden that is a
generic version of GlaxoSmithKline Plc's Advair, a move
that will further dent sales of the British firm's top-selling
Cipla's drug will be marketed under the name Serrofloin in
Germany and Salmeterol/Fluticasone Cipla in Sweden, the
Mumbai-based company said in a statement on Monday.
In December, Denmark became the first European country to
approve for sale a generic version of GlaxoSmithKline's $8
billion-a-year Advair, and analysts have been expecting more
Making copies of inhaled drugs such as Advair is a challenge
because of the complexity of making a device that effectively
delivers the medicine directly into the lungs.
(Reporting by Zeba Siddiqui in Mumbai; Editing by Prateek